Evidence map›Paper›PMID 39998736›Full record

ArticleJapanese journal of radiology2025

Predictive classification of lung cancer pathological based on PET/CT radiomics.

Mengye Peng, Menglu Wang, Wenxin An, Tingting Wu, Ying Zhang, Fan Ge, Liang Cheng, Wei Liu, Kezheng Wang

Abstract read
PubMed Publisher
In one paragraph

Article in Japanese journal of radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Evaluating the prognostic impact of multipleEuropean journal of nuclear medicine and molecular imaging · 2026
    Trial
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mengye PengPET-CT/MRI Department, Harbin Medical University Cancer Hospital, No.150 Haping Road, Harbin, Heilongjiang, China.
Menglu WangPET-CT/MRI Department, Harbin Medical University Cancer Hospital, No.150 Haping Road, Harbin, Heilongjiang, China.
Wenxin AnDepartment of Urology, Harbin Medical University Cancer Hospital, No.150 Haping Road, Harbin, Heilongjiang, China.
Tingting WuPET-CT/MRI Department, Harbin Medical University Cancer Hospital, No.150 Haping Road, Harbin, Heilongjiang, China.
Ying ZhangPET-CT/MRI Department, Harbin Medical University Cancer Hospital, No.150 Haping Road, Harbin, Heilongjiang, China.
Fan GePET-CT/MRI Department, Harbin Medical University Cancer Hospital, No.150 Haping Road, Harbin, Heilongjiang, China.
Liang ChengPET-CT/MRI Department, Harbin Medical University Cancer Hospital, No.150 Haping Road, Harbin, Heilongjiang, China.
Wei LiuPET-CT/MRI Department, Harbin Medical University Cancer Hospital, No.150 Haping Road, Harbin, Heilongjiang, China.
Kezheng WangPET-CT/MRI Department, Harbin Medical University Cancer Hospital, No.150 Haping Road, Harbin, Heilongjiang, China. wangkezheng9954001@163.com.

Funding

Distinguished Young Scientist Funding of Harbin Medical University Affiliated Tumor Hospital JCQN2019-02Key Innovation Technology Project Harbin Medical University Cancer Hospital Innovation Technology Funding CXJSZD-2023-04Key Project of Harbin Medical University Cancer Hospital Climbing Funding PDYS2024-03Provincial Key Research and Development Program of Heilongjiang Province GA21C001 KW
6 · The paper itself

Abstract

objectivesTo develop and validate a combined clinical and radiomics model for non-invasive prediction of lung cancer (LC) pathological types (lung adenocarcinoma, lung squamous cell carcinoma, and small cell lung cancer) based on patients' pre-treatment FDG PET/CT images and clinical data, as a complementary tool to aid in the diagnosis of LC pathological histological classification.

methodsIn total, 896 patients with pathological confirmation of lung cancer were part of this retrospective study. The training and test groups included 819 patients who underwent scanning using scanner 1. The independent validation group included 77 patients who using scanner 2. The optimal features were retained by least absolute shrinkage and selection operator algorithm dimensionality reduction screening of the collected radiomics features, clinical parameters, and PET metabolic parameters. Five models were established to predict the lung cancer pathological types by the k-nearest neighbor classification (KNN) algorithm. The performance of the prediction model was assessed by calculating the area under the curve (AUC) from the receiver operator characteristic curve (ROC).

resultsOf all five predictive models (the PET-only radiomics model, the CT-only radiomics model, the PET/CT radiomics model, the clinical-only model and the combined clinical and PET/CT radiomics model), the clinical combined PET/CT radiomics model exhibited best performance. The macro-AUC for the training, test and independent validation groups were 0.974, 0.931, 0.960, the micro-AUC were 0.976, 0.940, 0.970, and the accuracy were 0.963, 0.914, and 0.961, respectively.

conclusionsOur model combined radiomics and clinical data and showed higher performance in non-invasively predicting the LC pathological types, which suggesting that PET/CT radiomics may be a promising technique for predicting LC histopathology.

Indexed as

Lung NeoplasmsPositron Emission Tomography Computed TomographyAdultAgedAged, 80 and overAlgorithmsFemaleFluorodeoxyglucose F18HumansLungMaleMiddle AgedPredictive Value of TestsRadiomicsRadiopharmaceuticalsRetrospective StudiesFluorodeoxyglucose F18Radiopharmaceuticals18F-FDG PET/CTLung cancerRadiomics

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.